Order Article Reprints

Conley AP, Wang W-L, Livingston JA, Ravi V, Tsai J-W, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, et al. MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers. 2019; 11(5):677. https://doi.org/10.3390/cancers11050677

Conley, Anthony P., Wei-Lien Wang, John A. Livingston, Vinod Ravi, Jen-Wei Tsai, Ali Ali, Davis R. Ingram, Caitlin D. Lowery, Christina L. Roland, Neeta Somaiah, and et al. 2019. "MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma" Cancers 11, no. 5: 677. https://doi.org/10.3390/cancers11050677

Conley, A. P., Wang, W.-L., Livingston, J. A., Ravi, V., Tsai, J.-W., Ali, A., Ingram, D. R., Lowery, C. D., Roland, C. L., Somaiah, N., Hwu, P., Yee, C., Subbiah, V., Futreal, A., Lazar, A. J., Patel, S., & Roszik, J. (2019). MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers, 11(5), 677. https://doi.org/10.3390/cancers11050677